Small molecule inhibitors of the mitochondrial ClpXP protease possess cytostatic potential and re-sensitize chemo-resistant cancers
Abstract The human mitochondrial ClpXP protease complex (HsClpXP) has recently attracted major attention as a target for novel anti-cancer therapies. Despite its important role in disease progression, the cellular role of HsClpXP is poorly characterized and only few small molecule inhibitors have be...
Guardado en:
Autores principales: | Martina Meßner, Melanie M. Mandl, Mathias W. Hackl, Till Reinhardt, Maximilian A. Ardelt, Karolina Szczepanowska, Julian E. Frädrich, Jens Waschke, Irmela Jeremias, Anja Fux, Matthias Stahl, Angelika M. Vollmar, Stephan A. Sieber, Johanna Pachmayr |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/547435541d554b50bc1ec5f3fc98a476 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Regulation of Antimycin Biosynthesis Is Controlled by the ClpXP Protease
por: Bohdan Bilyk, et al.
Publicado: (2020) -
Functional cooperativity between the trigger factor chaperone and the ClpXP proteolytic complex
por: Kamran Rizzolo, et al.
Publicado: (2021) -
Author Correction: Functional cooperativity between the trigger factor chaperone and the ClpXP proteolytic complex
por: Kamran Rizzolo, et al.
Publicado: (2021) -
Drosophila protease ClpXP specifically degrades DmLRPPRC1 controlling mitochondrial mRNA and translation
por: Yuichi Matsushima, et al.
Publicado: (2017) -
Optimization of ClpXP activity and protein synthesis in an E. coli extract-based cell-free expression system
por: Xinying Shi, et al.
Publicado: (2018)